Wedbush reiterates Outperform on Nuvation Bio; $11 price target
Wedbush reiterated an Outperform rating on Nuvation Bio and set a $11.00 price target, implying 89.7% upside versus the Sep 15 close of $5.80.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.